[Heparin-induced thrombocytopenia in patients on hemodialysis].
Matsuo
Takefumi
T
Hyogo Prefectural Awaji Hospital.
D000925:Anticoagulants / Q000009:adverse effects*; D001120:Arginine / Q000031:analogs & derivatives; D001550:Benzamidines; D006146:Guanidines; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D010875:Pipecolic Acids; D006435:Renal Dialysis; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
D000925:Anticoagulants; D001550:Benzamidines; D006146:Guanidines; D006495:Heparin, Low-Molecular-Weight; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban; C032855:nafamostat